doi: 10.1002/1097-0142(197609)38:3<1438::aid-cncr2820380351>3.0.co;2-2.
Second-look operation in ovarian carcinoma: postchemotherapy
- PMID: 953977
- DOI: 10.1002/1097-0142(197609)38:3<1438::aid-cncr2820380351>3.0.co;2-2
Item in Clipboard
Second-look operation in ovarian carcinoma: postchemotherapy
Cancer.
1976 Sep.
Abstract
One hundred and three patients with advanced ovarian cancer underwent a second-look operation following chemotherapy. Patients should have ten or more courses of chemotherapy before second-look operation. Those patients with no evidence of disease at second laparotomy should discontinue their chemotherapy. Patients who continued chemotherapy after the second-look operation did better than those who were treated with radiation after surgery. Only patients with clinical remission benefit from the second-look procedure. Advantages of second-look operations following chemotherapy are discussed.
Similar articles
-
Second-look operations in ovarian cancer.Am J Obstet Gynecol. 1980 Dec 15;138(8):1124-30. doi: 10.1016/s0002-9378(16)32778-8. Am J Obstet Gynecol. 1980. PMID: 7446620
-
Sequential therapy for advanced ovarian adenocarcinoma: operation, chemotherapy, second-look laparotomy, and radiation therapy.Am J Obstet Gynecol. 1975 Jun 1;122(3):355-7. doi: 10.1016/0002-9378(75)90183-0. Am J Obstet Gynecol. 1975. PMID: 1168999
-
Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma.J Surg Oncol. 1982 Nov;21(3):159-61. doi: 10.1002/jso.2930210305. J Surg Oncol. 1982. PMID: 6813600
-
Second-look laparotomy in ovarian cancer.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S122-7. doi: 10.1006/gyno.1994.1350. Gynecol Oncol. 1994. PMID: 7835795 Review.
-
Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S97-107. doi: 10.1006/gyno.1994.1347. Gynecol Oncol. 1994. PMID: 7835816 Review.
Cited by
-
Second look laparotomy in the management of epithelial cell carcinoma of the ovary.Br J Cancer. 1984 Aug;50(2):185-91. doi: 10.1038/bjc.1984.161. Br J Cancer. 1984. PMID: 6466536 Free PMC article.
-
Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial.Cancer Chemother Pharmacol. 1985;14(3):222-8. doi: 10.1007/BF00258120. Cancer Chemother Pharmacol. 1985. PMID: 3922639 Clinical Trial.
-
Obstetrics and gynecology-epitomes of progress: a second-look operation in the management of patients with carcinoma of the ovary.West J Med. 1980 Mar;132(3):234-5. West J Med. 1980. PMID: 18748573 Free PMC article. No abstract available.
-
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.Br J Cancer. 1984 Dec;50(6):765-9. doi: 10.1038/bjc.1984.254. Br J Cancer. 1984. PMID: 6208925 Free PMC article.
-
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.Gynecol Oncol. 2016 Dec;143(3):511-515. doi: 10.1016/j.ygyno.2016.09.005. Epub 2016 Sep 28. Gynecol Oncol. 2016. PMID: 27692669 Free PMC article. Clinical Trial.